Search Results - "Mitchell, Jessica L."

Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study by Hubbard, Joleen M, Tőke, Enikő R, Moretto, Roberto, Graham, Rondell P, Youssoufian, Hagop, Lőrincz, Orsolya, Molnár, Levente, Csiszovszki, Zsolt, Mitchell, Jessica L, Wessling, Jaclynn, Tóth, József, Cremolini, Chiara

“…Although chemotherapy is standard of care for metastatic colorectal cancer (mCRC), immunotherapy has no role in microsatellite stable (MSS) mCRC, a "cold"…”
Get full text

Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis by Storandt, Michael H, Rogen, Kara R, Iyyangar, Anushka, Schnell, Rylie R, Mitchell, Jessica L, Hubbard, Joleen M, Sinicrope, Frank A, Jatoi, Aminah, Mahipal, Amit, Shi, Qian, Jin, Zhaohui

“…Over the past 20 years, rates of early-onset colorectal cancer (eoCRC), defined as <50 years of age at diagnosis, have increased, with 16-25% associated with a…”
Get full text

Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer by Smith, Caleb J., Bekaii-Saab, Tanios S., Cook, Kathryn D., Eiring, Rachel A., Halfdanarson, Thorvardur R., Hanna, Mina, Jin, Zhaohui, Jochum, Jacob A., Ma, Wen Wee, Mitchell, Jessica L., Pitot, Henry C., Jatoi, Aminah

“…Nanoliposomal irinotecan (Nal-IRI) is a preferred second-line treatment for metastatic pancreas cancer. It is unclear, however, whether patients who had…”
Get full text

Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer by O'Donnell, Conor D J, Naleid, Nikolas, Siripoon, Teerada, Zablonski, Kevin G, Storandt, Michael H, Selfridge, Jennifer E, Hallemeier, Christopher L, Conces, Madison L, Jethwa, Krishan R, Bajor, David L, Thiels, Cornelius A, Warner, Susanne G, Starlinger, Patrick P, Atwell, Thomas D, Mitchell, Jessica L, Mahipal, Amit, Jin, Zhaohui

“…(1) Background: Local therapies offer a potentially curative approach for patients with oligometastatic colorectal cancer (CRC). An evidence-based consensus…”
Get full text

The Counselor’s Trauma as Counseling Motivation: Vulnerability or Stress Inoculation? by Jenkins, Sharon Rae, Mitchell, Jessica L., Baird, Stephanie, Whitfield, Sarah Roby, Meyer, Heather Lynn

“…Should counselors with interpersonal trauma histories work with similarly traumatized clients? How does the work affect them? Current research is inconsistent…”
Get full text

Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer by Bartlett, David J., Childs, Daniel S., Breitkopf, Carmen Radecki, Grudem, Megan E., Mitchell, Jessica L., Looker, Sherry A., Ridgeway, Jennifer L., Lee, Jennifer L., Butterfield, Joseph H., Weroha, S. John, Jatoi, Aminah

“…Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied…”
Get full text

Prognostic value of circulating tumor DNA following local therapy in colorectal cancer with liver metastases by O'Donnell, Conor, Storandt, Michael H., Mitchell, Jessica L., Jin, Zhaohui

“…26 Background: Local therapies have the potential to cure a portion of patients with colorectal cancer with liver-only metastatic disease (CRLM)…”
Get full text

A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer by Storandt, Michael H., Emiloju, Oluwadunni Eunice, Zemla, Tyler J., McWilliams, Robert R., Sinicrope, Frank A., Mitchell, Jessica L., Shi, Qian, Jin, Zhaohui

“…227 Background: Circulating tumor DNA (ctDNA) consists of small fragments of DNA released into the plasma from cancer cells. Tumor informed ctDNA testing by…”
Get full text

Systemic treatment post curative-intent intervention based on tumor-informed circulating tumor DNA result for oligometastatic colorectal cancer by Siripoon, Teerada, O'Donnell, Conor, Naleid, Nikolas, Starlinger, Patrick, Atwell, Thomas D., Thiels, Cornelius A, Warner, Susanne, Mitchell, Jessica L., Jethwa, Krishan, Hallemeier, Christopher Leigh, Mathis, Kellie Leanne, Shawki, Sherief, Mahipal, Amit, Jin, Zhaohui

“…84 Background: Local therapies potentially offer a curative approach for patients with oligometastatic colorectal cancer (CRC). The effectiveness of systemic…”
Get full text

PolyPEPI1018 vaccine in combination with TAS-102 in participants with late-stage microsatellite-stable metastatic colorectal cancer (MSS mCRC): A phase Ib study to evaluate safety, tolerability, immunogenicity and efficacy (OBERTO-201) by Hubbard, Joleen M., Zemla, Tyler J., Graham, Rondell P., Jin, Zhaohui, Zhu, Mojun, Mitchell, Jessica L., Novo, Elise, Vegh, Eva, Lorincz, Orsolya, Csiszovszki, Zsolt, Kremlitzka, Mariann, Somogyi, Eszter, Molnar, Levente, Tóth, József, Toke, Eniko Rita

“…3595 Background: PolyPEPI1018 is an off-the-shelf, multi-peptide vaccine containing 12 immunogenic epitopes derived from 7 tumor-specific antigens frequently…”
Get full text

Phase Ib open-label study to evaluate safety, tolerability, immunogenicity, and efficacy of multiple subcutaneous injections of PolyPEPI1018 vaccine as an add-on immunotherapy to TAS-102 in participants with late-stage microsatellite-stable metastatic colorectal cancer (MSS mCRC; OBERTO-201) by Hubbard, Joleen M., Zemla, Tyler J., Graham, Rondell P., Jin, Zhaohui, Zhu, Mojun, Mitchell, Jessica L., Novo, Elise, Vegh, Eva, Lorincz, Orsolya, Kremlitzka, Mariann, Somogyi, Eszter, Molnar, Levente, Tóth, József, Toke, Eniko Rita

“…147 Background: PolyPEPI1018 is an off-the-shelf, multi-peptide vaccine containing 12 immunogenic epitopes derived from 7 cancer testis antigens (CTAs)…”
Get full text

Clinical outcomes of neoadjuvant treatment strategies in localized mismatch repair-deficient rectal cancer by Soderberg, Leah C, Wookey, Vanessa, Mitchell, Jessica L., Jochum, Jacob A., Tran, Nguyen H., Halfdanarson, Thorvardur Ragnar, Hubbard, Joleen M., Graham, Rondell P., Mathis, Kellie Leanne, Mahipal, Amit, Jin, Zhaohui

“…Abstract only 192 Background: Rectal cancer treatment paradigm has been evolving over time. Historically, for locally advanced rectal cancer, standard therapy…”
Get full text

Nanoliposomal irinotecan-based chemotherapy after regular irinotecan-based chemotherapy in patients with pancreas cancer by Smith, Caleb J, Bekaii-Saab, Tanios S., Cook, Kathryn, Eiring, Rachel, Halfdanarson, Thorvardur Ragnar, Hanna, Mina Samir Erian, Jin, Zhaohui, Jochum, Jacob A., Ma, Wen Wee, Mitchell, Jessica L, Pitot, Henry C., Jatoi, Aminah

“…Abstract only 402 Background: Pancreas cancer is an aggressive malignancy with limited therapeutic options. Nanoliposomal irinotecan (Nal-IRI) is a preferred…”
Get full text

Evaluation of safety, immunogenicity, and preliminary efficacy of PolyPEPI1018 off-the-shelf vaccine with fluoropyrimidine/bevacizumab maintenance therapy in metastatic colorectal cancer (mCRC) patients by Hubbard, Joleen Marie, Cremolini, Chiara, Graham, Rondell P., Moretto, Roberto, Mitchell, Jessica L, Wessling, Jaclynn, Toke, Eniko Rita, Csiszovszki, Zsolt, Lőrincz, Orsolya, Molnar, Levente, Somogyi, Eszter, Megyesi, Mónika, Pantya, Kata, Tóth, József, Páles, Péter, Miklós, István, Falcone, Alfredo

“…Abstract only 4048 Background: PolyPEPI1018 is an off-the-shelf, multi-peptide vaccine containing 12 immunogenic epitopes derived from 7 cancer testis antigens…”
Get full text

The relationship between interpersonal dependency and therapeutic alliance: Perspectives of clients and therapists by Mitchell, Jessica L

“…Both interpersonal dependency and the importance of the therapeutic alliance to successful psychotherapy outcomes have been widely studied. However, these two…”
Get full text

Individual perceptions of a proposed pressure to be positive in America by Mitchell, Jessica L

“…Positive psychology has become influential in research and practice. However, some have criticized positive psychologists who focus solely on the virtues of…”
Get full text